Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

RVL Pharmaceuticals plc (OSMT) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $1.10 Metrics
OS: 99.5 M -418 % ROE
Market cap: $109 M -181 % ROIC
Net debt: $65.3 M
EV: $175 M

 
TTM Valuation
EBITDA ($47.7) M
EBIT ($48.1) M
EPS ($0.48)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
Revenues49.717.527.8240.0263.7245.7 
            Revenue growth184.1%-37.0%-88.4%-9.0%7.3%  
Cost of goods sold9.53.63.3111.6140.1125.2 
Gross profit40.313.924.5128.4123.6120.6 
            Gross margin81.0%79.3%88.1%53.5%46.9%49.1% 
Selling, general and administrative82.087.572.893.074.257.0 
Research and development4.06.913.432.343.742.7 
EBITA-45.7-60.7-61.755.782.8-8.7 
            EBITA margin-91.9%-346.7%-222.4%23.2%31.4%-3.5% 
Amortization of intangibles   52.777.143.4 
EBIT-45.7-60.7-61.73.15.7-52.1 
            EBIT margin-91.9%-346.7%-222.4%1.3%2.2%-21.2% 
Pre-tax income-51.7-82.5-94.8-298.0-118.7-85.6 
Income taxes0.00.3-5.8-27.1-9.0-44.5 
            Tax rate0.0% 6.1%9.1%7.6%52.0% 
Net income-51.7-64.9-79.6-270.9-109.7-41.1 
            Net margin-104.0%-371.0%-286.7%-112.9%-41.6%-16.7% 
 
Diluted EPS($0.58)($1.23)($1.47)($5.17)($2.42)($0.96) 
Shares outstanding (diluted)89.867.460.752.445.342.9 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy